Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae | Zendy

Adam Johnson | Zendy; Laura McEntee | Zendy; Nicola Farrington | Zendy; Ruwanthi KolamunnageDona | Zendy; Samantha Franzoni | Zendy; A. Vezzelli | Zendy; Mameli Massimiliano | Zendy; Philipp Knechtle | Zendy; Adam Belley | Zendy; Aaron Dane | Zendy; George L. Drusano | Zendy; Shampa Das | Zendy; William Hope | Zendy

Open Access

Pharmacodynamics of Cefepime Combined with the Novel Extended-Spectrum-β-Lactamase (ESBL) Inhibitor Enmetazobactam for Murine Pneumonia Caused by ESBL-Producing Klebsiella pneumoniae

Author(s) -

Adam Johnson,

Laura McEntee,

Nicola Farrington,

Ruwanthi KolamunnageDona,

Samantha Franzoni,

A. Vezzelli,

Mameli Massimiliano,

Philipp Knechtle,

Adam Belley,

Aaron Dane,

George L. Drusano,

Shampa Das,

William Hope

Publication year - 2020

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00180-20

Subject(s) - cefepime , klebsiella pneumoniae , pneumonia , pharmacodynamics , klebsiella pneumonia , microbiology and biotechnology , medicine , cephalosporin , antibiotics , pharmacokinetics , virology , pharmacology , biology , bacteria , antibiotic resistance , pseudomonas aeruginosa , imipenem , escherichia coli , biochemistry , genetics , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research